Mandarin Capital Partners has acquired a majority stake in Mipharm Spa, an Italian contract manufacturing organization engaged in the manufacturing and packaging of a wide range of drugs, the Sino-Europe private equity firm said today.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!
Register NowAlready have an account or paid subscription? Log in
